Article

Pharmacovigilance Programme of India: System put in place to Report Adverse Drug Reactions

Vivekanandan Kalaiselvan1, Ismeet Kaur1★, Surinder Singh2, Gyanendra N Singh1★ Corresponding author

  1. 1Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt of India, Sector 23, Rajnagar, Ghaziabad, U.P.-201002, India.
  2. 2National Institute of Biologics (NIB), Ministry of Health & Family Welfare, Govt.of India, Plot No. A-32, Sector-62, Institutional Area, NOIDA, U.P.-201 309, India.

CORRESPONDENCE

Ismeet Kaur

Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt of India, Sector 23, Rajnagar, Ghaziabad, U.P.-201002, India.

ishunarang12@gmail.com

Received: 03-12-2014; Revised: 22-06-2015; Accepted: 19-07-2015.

Volume 50, Issue 1 · pp. s212–s214 · PUBLISHED 2016 · DOI: 10.5530/ijper.50.1.26

View on IJPER original site ↗

ABSTRACT

Dear Editor, Adverse drug reaction (ADRs) is response to a drug which is noxious and unintended and which occurs at doses normally used in human for the prophylaxis, diagnosis or treatment of disease, or for the modification of physiological function. ADRs are one of the major public health issues and found to cause of morbidity and mortality. The impact of ADRs in India is significant and leads to the enormous burden to the public. Therefore, Ministry of Health & Family Welfare (MoHFW), Government of India launched a nationwide Pharmacovigilance Programme of India (PvPI) in the year 2010 to monitor the safety of drugs. Indian Pharmacopoeia Commission (IPC) under the MoHFW functions as National Coordination Centre (NCC) for PvPI. To monitor and report ADRs to NCC, teaching hospitals and corporate hospitals have been identified as ADRs Monitoring Centres (AMCs).

KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Kalaiselvan, V., Kaur, I., Singh, S., & Singh, G. N. (2016). Pharmacovigilance Programme of India: System put in place to Report Adverse Drug Reactions. Indian Journal of Pharmaceutical Education and Research, 50(1), s212–s214. https://doi.org/10.5530/ijper.50.1.26